T/SHPPA 002-2020 Active Group standards

T/SHPPA 002-2020 Narrow therapeutic index drug quality evaluation and standard development generic technical requirements

T/SHPPA 002-2020 Narrow therapeutic index drug quality evaluation and standard development generic technical requirements

Publish Date: 2020-05-20 Implement Date: 2020-07-01 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 20.00
Out of stock

Basic Information

Standard Code: T/SHPPA 002-2020
Standard Type: Group standards
Standard Status: Active
is_force_gb: no
CCS Name: Medicine, health, and labor protection
ICS Name: Quality management and quality assurance
Publish Date: 2020-05-20
Implement Date: 2020-07-01

Scope

Scope: This document is applicable to the quality evaluation and standard formulation of narrow therapeutic index drugs; Main technical content: The formulation of this document refers to the relevant laws, regulations, and technical requirements related to narrow therapeutic index drugs, and is based on the research data and clinical monitoring data of existing narrow therapeutic index drugs in R&D, production, circulation, and use. Based on the characteristics of NTIDs and the risks of clinical use, this technical requirement takes quality management as the core and makes provisions in terms of quality evaluation and the establishment of quality standards.

Development Information

Related Standards

Contact Us